MILLIPRED

Trx Pharmaceuticals, Llc

Application Filed: 2012-08-23

Trademark Application Details

Status

702

Live/Registered

SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Research	OneLook Acronym Finder
Serial Number	85711187
Registration Number	4327770
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Julia C. Archer
Law Office Assigned	L20
Employee Name	SAITO, KIM TSUKIYO

Timeline

2008-10-01	Date of First Use
2012-08-23	Application Filed
2013-02-12	Published for Opposition
2013-04-30	Trademark Registered
2019-06-07	Location: TMEG LAW OFFICE 102
2019-06-07	Status: Live/Registered
2019-06-08	Transaction Date

Trademark Applicants & Owners

Owner:	TRX PHARMACEUTICALS, LLC
Address	540 Gaither Road SUITE 400 Rockville NC 20850
Legal Entity Type	Limited Liability Company
Legal Entity State	NC

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Julia C. Archer
Enns & Archer LLP
939 Burke Street, Suite E
Winston-Salem, NC 27101

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations containing prednisolone for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system; Pharmaceutical preparations containing prednisolone for the treatment of inflammatory disorders; Pharmaceutical preparations containing prednisolone for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders

Type Code

Type

GS0051

Pharmaceutical preparations containing prednisolone for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculoskeletal system, the genitourinary system; Pharmaceutical preparations containing prednisolone for the treatment of inflammatory disorders; Pharmaceutical preparations containing prednisolone for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2012-08-27	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2012-09-06	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2012-12-17	3 DOCK D:Assigned to Examiner
EXAMINERS AMENDMENT -WRITTEN	2012-12-19	4 CNEA R:Renewal
EXAMINERS AMENDMENT E-MAILED	2012-12-19	5 GNEA F:First Action
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED	2012-12-19	6 GNEN O:Outgoing Correspondence
EXAMINER'S AMENDMENT ENTERED	2012-12-19	7 XAEC I:Incoming Correspondence
APPROVED FOR PUB - PRINCIPAL REGISTER	2012-12-19	8 CNSA O:Outgoing Correspondence
ASSIGNED TO LIE	2013-01-09	9 ALIE A:Allowance for Publication
LAW OFFICE PUBLICATION REVIEW COMPLETED	2013-01-09	10 PREV O:Outgoing Correspondence
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	2013-01-23	11 NONP E:E-Mail
PUBLISHED FOR OPPOSITION	2013-02-12	12 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2013-02-12	13 NPUB E:E-Mail
REGISTERED-PRINCIPAL REGISTER	2013-04-30	14 R.PR A:Allowance for Publication
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2013-05-29	15 ASGN I:Incoming Correspondence
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2013-09-04	16 ASGN I:Incoming Correspondence
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED	2018-04-30	17 REM1 E:E-Mail
TEAS WITHDRAWAL OF ATTORNEY RECEIVED	2018-05-02	18 WOAR I:Incoming Correspondence
WITHDRAWAL OF ATTORNEY GRANTED	2018-05-02	19 WOAG I:Incoming Correspondence
TEAS SECTION 8 & 15 RECEIVED	2019-04-25	20 E815 I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2019-06-07	21 APRE A:Allowance for Publication
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.	2019-06-07	22 C15A O:Outgoing Correspondence
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED	2019-06-07	23 NA85 E:E-Mail
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED	2022-04-30	24 REM2 E:E-Mail
TEAS SECTION 8 & 9 RECEIVED	2023-04-18	25 E89R I:Incoming Correspondence
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP	2023-04-19	26 ASGN I:Incoming Correspondence
CASE ASSIGNED TO POST REGISTRATION PARALEGAL	2023-10-18	27 APRE A:Allowance for Publication
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED	2023-10-18	28 89AG O:Outgoing Correspondence
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)	2023-10-18	29 RNL1 Q:
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED	2023-10-18	30 NA89 E:E-Mail

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
MILLIPRED 85711187 4327770 Live/Registered	TRX PHARMACEUTICALS, LLC 2012-08-23
MILLIPRED 77369190 not registered Dead/Abandoned	Laser Pharmaceuticals, LLC 2008-01-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.